414 related articles for article (PubMed ID: 19096022)
1. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
Fernández-Velasco M; Rueda A; Rizzi N; Benitah JP; Colombi B; Napolitano C; Priori SG; Richard S; Gómez AM
Circ Res; 2009 Jan; 104(2):201-9, 12p following 209. PubMed ID: 19096022
[TBL] [Abstract][Full Text] [Related]
2. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
Neco P; Torrente AG; Mesirca P; Zorio E; Liu N; Priori SG; Napolitano C; Richard S; Benitah JP; Mangoni ME; Gómez AM
Circulation; 2012 Jul; 126(4):392-401. PubMed ID: 22711277
[TBL] [Abstract][Full Text] [Related]
4. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
Chen B; Guo A; Gao Z; Wei S; Xie YP; Chen SR; Anderson ME; Song LS
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):841-9. PubMed ID: 22722659
[TBL] [Abstract][Full Text] [Related]
5. R4496C RyR2 mutation impairs atrial and ventricular contractility.
Ferrantini C; Coppini R; Scellini B; Ferrara C; Pioner JM; Mazzoni L; Priori S; Cerbai E; Tesi C; Poggesi C
J Gen Physiol; 2016 Jan; 147(1):39-52. PubMed ID: 26666913
[TBL] [Abstract][Full Text] [Related]
6. Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
Bai Y; Jones PP; Guo J; Zhong X; Clark RB; Zhou Q; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Semeniuk L; Guo A; Song LS; Duff HJ; Chen SR
Circ Res; 2013 Aug; 113(5):517-26. PubMed ID: 23856523
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.
Liu N; Colombi B; Memmi M; Zissimopoulos S; Rizzi N; Negri S; Imbriani M; Napolitano C; Lai FA; Priori SG
Circ Res; 2006 Aug; 99(3):292-8. PubMed ID: 16825580
[TBL] [Abstract][Full Text] [Related]
8. In the RyR2(R4496C) mouse model of CPVT, β-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves.
Kashimura T; Briston SJ; Trafford AW; Napolitano C; Priori SG; Eisner DA; Venetucci LA
Circ Res; 2010 Dec; 107(12):1483-9. PubMed ID: 20966392
[TBL] [Abstract][Full Text] [Related]
9. Targeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigation.
Sung RJ; Lo CP; Hsiao PY; Tien HC
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1625-38. PubMed ID: 21742998
[TBL] [Abstract][Full Text] [Related]
10. Subclinical abnormalities in sarcoplasmic reticulum Ca(2+) release promote eccentric myocardial remodeling and pump failure death in response to pressure overload.
Sedej S; Schmidt A; Denegri M; Walther S; Matovina M; Arnstein G; Gutschi EM; Windhager I; Ljubojević S; Negri S; Heinzel FR; Bisping E; Vos MA; Napolitano C; Priori SG; Kockskämper J; Pieske B
J Am Coll Cardiol; 2014 Apr; 63(15):1569-79. PubMed ID: 24315909
[TBL] [Abstract][Full Text] [Related]
11. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
Uchinoumi H; Yano M; Suetomi T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
Circ Res; 2010 Apr; 106(8):1413-24. PubMed ID: 20224043
[TBL] [Abstract][Full Text] [Related]
12. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.
Liu N; Ruan Y; Denegri M; Bachetti T; Li Y; Colombi B; Napolitano C; Coetzee WA; Priori SG
J Mol Cell Cardiol; 2011 Jan; 50(1):214-22. PubMed ID: 20937285
[TBL] [Abstract][Full Text] [Related]
13. Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.
Liu N; Denegri M; Ruan Y; Avelino-Cruz JE; Perissi A; Negri S; Napolitano C; Coetzee WA; Boyden PA; Priori SG
Circ Res; 2011 Jul; 109(3):291-5. PubMed ID: 21680895
[TBL] [Abstract][Full Text] [Related]
14. CaMKII inhibition has dual effects on spontaneous Ca
Sadredini M; Haugsten Hansen M; Frisk M; Louch WE; Lehnart SE; Sjaastad I; Stokke MK
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H446-H460. PubMed ID: 34270372
[TBL] [Abstract][Full Text] [Related]
15. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
[TBL] [Abstract][Full Text] [Related]
16. Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia.
Herron TJ; Milstein ML; Anumonwo J; Priori SG; Jalife J
Heart Rhythm; 2010 Aug; 7(8):1122-8. PubMed ID: 20538074
[TBL] [Abstract][Full Text] [Related]
17. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
Gellen B; Fernández-Velasco M; Briec F; Vinet L; LeQuang K; Rouet-Benzineb P; Bénitah JP; Pezet M; Palais G; Pellegrin N; Zhang A; Perrier R; Escoubet B; Marniquet X; Richard S; Jaisser F; Gómez AM; Charpentier F; Mercadier JJ
Circulation; 2008 Apr; 117(14):1778-86. PubMed ID: 18378612
[TBL] [Abstract][Full Text] [Related]
18. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.
Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S
Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CaMKIIδc in RyR2R4496C+/- knock-in mice leads to altered intracellular Ca2+ handling and increased mortality.
Dybkova N; Sedej S; Napolitano C; Neef S; Rokita AG; Hünlich M; Brown JH; Kockskämper J; Priori SG; Pieske B; Maier LS
J Am Coll Cardiol; 2011 Jan; 57(4):469-79. PubMed ID: 21251589
[TBL] [Abstract][Full Text] [Related]
20. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
Cerrone M; Noujaim SF; Tolkacheva EG; Talkachou A; O'Connell R; Berenfeld O; Anumonwo J; Pandit SV; Vikstrom K; Napolitano C; Priori SG; Jalife J
Circ Res; 2007 Nov; 101(10):1039-48. PubMed ID: 17872467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
